MEK1/2 inhibition ameliorates clinical lesions in experimental pemphigus vulgaris
Molecular Therapy
· Elsevier
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Читать у издателя →
Цитирование
MEK1/2 inhibition ameliorates clinical lesions in experimental pemphigus vulgaris. // Molecular Therapy. – URL: https://www.sciencedirect.com/science/article/pii/S1525001626009391?dgcid=rss_sd_all
MEK1/2 inhibition ameliorates clinical lesions in experimental pemphigus vulgaris. Molecular Therapy. https://www.sciencedirect.com/science/article/pii/S1525001626009391?dgcid=rss_sd_all
“MEK1/2 inhibition ameliorates clinical lesions in experimental pemphigus vulgaris.” Molecular Therapy.
@article{article59188,
title = {MEK1/2 inhibition ameliorates clinical lesions in experimental pemphigus vulgaris},
journal = {Molecular Therapy},
url = {https://www.sciencedirect.com/science/article/pii/S1525001626009391?dgcid=rss_sd_all}
}